Polymyalgia Rheumatica (PMR) and Polymyalgia Rheumatica-like (PMR-like) Manifestations in Cancer Patients Following Treatment with Nivolumab and Pembrolizumab: Methodological Blurred Points Identified Through a Systematic Review of Published Case Reports

<b>Background</b>: Among rheumatologic diseases following therapy with immune checkpoint inhibitors (ICIs), the cases of cancer patients diagnosed as having polymyalgia rheumatica (PMR), particularly with nivolumab and pembrolizumab, has been steadily rising in published reports. <b>Objectives</b>:...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Ciro Manzo, Marco Isetta, Alberto Castagna, Melek Kechida
Format:	Artigo
Jezik:	Inglês
Izdano:	MDPI AG 2025-04-01
Serija:	Medical Sciences
Teme:	polymyalgia rheumatica immunotherapy immune checkpoints inhibitors systematic review adverse drug reaction case reports
Online dostop:	https://www.mdpi.com/2076-3271/13/2/34
Oznake:	Označite Brez oznak, prvi označite!